ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 42 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,787,000 | +39.2% | 1,719,111 | 0.0% | 0.05% | +2.0% |
| Q4 2018 | $1,284,000 | -76.9% | 1,719,111 | -34.4% | 0.05% | -67.1% |
| Q3 2018 | $5,556,000 | -8.2% | 2,620,897 | 0.0% | 0.15% | -6.3% |
| Q2 2018 | $6,054,000 | -27.4% | 2,620,897 | 0.0% | 0.16% | -31.8% |
| Q1 2018 | $8,334,000 | -22.4% | 2,620,897 | 0.0% | 0.23% | -34.6% |
| Q4 2017 | $10,745,000 | +14.5% | 2,620,897 | +26.2% | 0.36% | +98.9% |
| Q3 2017 | $9,386,000 | – | 2,076,578 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |